SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
16/07/2025
Voltar para busca
Dado oficial do USPTO
ATROPOS EVIDENCE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ATROPOS EVIDENCE
ST13
US500000097854125Classe
9, 35, 38, 42, 44
Pedido
97854125
Registro
7868580
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
22/07/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 35, 38, 42, 44
Data de depósito
23/03/2023
Data de registro
15/07/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/07/2025
Última transação
22/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
10/12/2020
Primeiro uso no comércio
10/12/2020
Código do desenho
4
Tipo de titular
03
Localização do titular
New York, NY
Examinador
RUIZ, AMANDA
Unidade examinadora
O50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Atropos Health, Inc.
Representantes
Thomas Y. Yee Perkins Coie LLP
Classificação técnica
Classes Nice
Classe 9Classe 35Classe 38Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable scientific and medical data via the internet
Classe 35
Business consulting and management in the field of clinical trialsproviding information management services
Classe 38
Providing access to an electronic exchange of health data and data analyses across an integrated nationwide clinical research network; transmission of database information and analyses of database information via telecommunications networks; electronic exchange of health data insights via telecommunication networks for analyses of health data from clinicianshealth systemsacademic medical centersothers
Classe 42
Providing medicalhealthscientific research informationresearch dataresearch services to assist healthcare providers and healthcare professionals in making informed decisions for patient diagnosis and treatment; providing medical and scientific research information in the field of clinical trials; compiling data for research purposes in the field of medical science and medical consultancy; software as a service (SAAS) services featuring software for providing patients diagnosis and treatments for physicians for use in database management; software as a service (SAAS) services featuring software for collectingstoringindexinganalyzingupdatingmanagingsharingreporting clinical trial data to evaluate and determine medical diagnosis and treatments; software as a service (SAAS) services featuring software for searchingorganizing and managing datademographicsdiagnosesproceduresmedicationslaboratory valuesclinical notesmortalitylength of stay information for patients to inform clinical care decisions and research; software as a service (SAAS) services featuring software for providing healthcare providers and healthcare professionals with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms
Classe 44
Providing medical information to healthcare providers and healthcare professionals to help them make informed decisions for patient diagnosis and treatment; providing tools to healthcare providers and healthcare professionals in the medical and patient-care industry to help them to assess clinical data for the purpose of patient diagnosis and treatment and improving quality of care in the medical and healthcare industryproviding tools in the nature of health assessment services; providing information and data related to patient datademographicsdiagnosesproceduresmedicationslaboratory valuesclinical notesmortalitylength of stay information for patients to inform clinical care decisions and research; providing on-line medical record analysis services designed to provide healthcare providers and healthcare professionals with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; providing on-line medical record analysis services designed to provide medical providers with custom tailored information about the outcomes for patients with similar symptoms and evidence needed for patient care decisions
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
15/07/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
15/07/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
24/06/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/04/2025
ALIE
ASSIGNED TO LIE
25/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/04/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
03/12/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
03/12/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/10/2024
GNRT
NON-FINAL ACTION E-MAILED
08/10/2024
CNRT
SU - NON-FINAL ACTION - WRITTEN
08/10/2024
EEXT
SOU TEAS EXTENSION RECEIVED
13/09/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
20/08/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
20/08/2024
IUAF
USE AMENDMENT FILED
25/06/2024
EISU
TEAS STATEMENT OF USE RECEIVED
25/06/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
19/03/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/01/2024
PUBO
PUBLISHED FOR OPPOSITION
23/01/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/01/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/12/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
20/12/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/12/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
20/12/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
20/12/2023
DOCK
ASSIGNED TO EXAMINER
18/12/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/08/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/08/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/08/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/08/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/08/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/04/2023
NWAP
NEW APPLICATION ENTERED
27/03/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ATROPOS EVIDENCE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.